Skip to main content
Have a personal or library account? Click to login
Distinct Morphological Features Predictive for Aggressiveness of Papillary Thyroid Microcarcinoma: a Study of 72 Cases and 80 Tumor Foci Cover

Distinct Morphological Features Predictive for Aggressiveness of Papillary Thyroid Microcarcinoma: a Study of 72 Cases and 80 Tumor Foci

Acta Marisiensis - Seria Medica
Volume 62 (2016): Issue 1 (March 2016)
By: ,  ,  ,  ,   and    
Open Access
|Feb 2016
References

References

  1. 1. DeLellis RA, Williams ED. Pathology of the thyroid and parathyroid. 2004;2:57-66.
    Search in Google Scholar
  2. 2. Davies L, Welch HG. Current thyroid cancer trends in the United States. JAMA Otolaryngol Head Neck Surg. 2014;140(4):317-322.
    Open DOISearch in Google Scholar
  3. 3. Davies L, Welch HG. Increasing incidence of thyroid cancer in the United States. 1973-2002. JAMA. 2006;295(18):2164-2167.
    Open DOISearch in Google Scholar
  4. 4. Enewold L, Zhu K, Ron E, et al. Rising thyroid cancer incidence in the United States by demographic and tumor characteristics. 1980-2005. Cancer Epidemiol Biomarkers Prev. 2009;18(3):784-791.
    Open DOISearch in Google Scholar
  5. 5. Ferlay J, Shin HR, Bray F, et al. GLOBOCAN 2008, Cancer Incidence and Mortality Worldwide: IARC Cancer Base No.10. http://globocan.iarc.fr. 2010.
    Search in Google Scholar
  6. 6. Hundahl SA, Fleming ID, Fremgen AM, Menck HR. A National Cancer Data Base report on 53,856 cases of thyroid carcinoma treated in the U.S. 1985-1995. Cancer. 1998;83(12):2638-2648.
    Open DOISearch in Google Scholar
  7. 7. Sassolas G, Hafdi-Nejjari Z, Remontet Let al. Thyroid cancer: is the incidence rise abating? Eur J Endocrinol. 2009;160(1):71-79.
    Open DOISearch in Google Scholar
  8. 8. Cătană R, Boilă A, Haifa Bet al. Time trends in thyroid pathology - a 20 year retrospective study. Acta Medica Marisiensis. 2010;56(6):534-537.
    Search in Google Scholar
  9. 9. Hughes DT, Haymart MR, Miller BSet al. The most commonly occurring papillary thyroid cancer in the United States is now a microcarcinoma in a patient older than 45 years. Thyroid. 2011;21(3):231-236.
    Open DOISearch in Google Scholar
  10. 10. Udelsman R, Zhang Y. The epidemic of thyroid cancer in the United States: the role of endocrinologists and ultrasounds. Thyroid. 2014;24(3):472-479.
    Open DOISearch in Google Scholar
  11. 11. Li N, Du XL, Reitzel LRet al. Impact of enhanced detection on the increase in thyroid cancer incidence in the United States: review of incidence trends by socioeconomic status within the surveillance, epidemiology, and end results registry, 1980-2008. Thyroid. 2013;23(1):103-110.
    Open DOISearch in Google Scholar
  12. 12. Yu XM, Wan Y, Sippel RS, Chen H. Should all papillary thyroid microcarcinomas be aggressively treated? An analysis of 18,445 cases. Ann Surg. 2011;254(4):653-660.
    Open DOISearch in Google Scholar
  13. 13. Pacini F. Management of papillary thyroid microcarcinoma: primum non nocere! J Clin Endocrinol Metab. 2013;98(4):1391-1393.
    Search in Google Scholar
  14. 14. Piana S, Ragazzi M, Tallini Get al. Papillary thyroid microcarcinoma with fatal outcome: evidence of tumor progression in lymph node metastases: report of 3 cases, with morphological and molecular analysis. Hum Pathol. 2013;44(4):556-565.
    Open DOISearch in Google Scholar
  15. 15. Page C, Biet A, Boute Pet al. ‘Aggressive papillary’ thyroid microcarcinoma. Eur Arch Otorhinolaryngol. 2009;266(12):1959-1963.
    Open DOISearch in Google Scholar
  16. 16. Virk RK, Van Dyke AL, Finkelstein Aet al. BRAFV600E mutation in papillary thyroid microcarcinoma: a genotype-phenotype correlation. Mod Pathol. 2013;26(1):62-70.
    Open DOISearch in Google Scholar
  17. 17. Virk RK, Theoharis CG, Prasad Aet al. Morphology predicts BRAF (V600E) mutation in papillary thyroid carcinoma: an interobserver reproducibility study. Virchows Arch. 2014;464(4):435-442.
    Open DOISearch in Google Scholar
  18. 18. Niemeier LA, Kuffner AH, Song Cet al. A combined molecular-pathologic score improves risk stratification of thyroid papillary microcarcinoma. Cancer. 2012;118(8):2069-2077.
    Open DOISearch in Google Scholar
  19. 19. Rossi ED, Bizzarro T, Fadda Get al. Is morphology alone able to predict BRAF-mutated malignancies on thyroid FNAC? Virchows Arch. 2014; 465(2):247-8;
    Open DOISearch in Google Scholar
  20. 20. Liu Z, Wang L, Yi Pet al. Risk factors for central lymph node metastasis of patients with papillary thyroid microcarcinoma: a meta-analysis. Int J Clin Exp Pathol. 2014;7(3):932-937.
    Search in Google Scholar
  21. 21. Hsiao SJ, Nikiforov YE. Molecular approaches to thyroid cancer diagnosis. Endocr Relat Cancer. 2014;21(5):T301-T313.
    Open DOISearch in Google Scholar
  22. 22. Lin KL, Wang OC, Zhang XHet al. The BRAF mutation is predictive of aggressive clinicopathological characteristics in papillary thyroid microcarcinoma. Ann Surg Oncol. 2010;17(12):3294-3300.
    Open DOISearch in Google Scholar
  23. 23. Rossi ED, Bizzarro T, Martini Met al. Morphological parameters able to predict BRAF(V600E) -mutated malignancies on thyroid fine-needle aspiration cytology: Our institutional experience. Cancer Cytopathol. 2014;122(12):883-891.
    Open DOISearch in Google Scholar
  24. 24. Finkelstein A, Levy GH, Hui Pet al. Papillary thyroid carcinomas with and without BRAF V600E mutations are morphologically distinct. Histopathology. 2012;60(7):1052-1059.
    Open DOISearch in Google Scholar
DOI: https://doi.org/10.1515/amma-2015-0112 | Journal eISSN: 2668-7763 (formerly 2247-6113) | Journal ISSN: 2668-7755
Journal RSS Feed
Language: English
Page range: 51 - 55
Submitted on: Aug 13, 2015
Accepted on: Sep 3, 2015
Published on: Feb 9, 2016
Published by: University of Medicine, Pharmacy, Science and Technology of Targu Mures
In partnership with: Paradigm Publishing Services
Publication frequency: 4 issues per year
Keywords:
thyroid,
papillary microcarcinoma,
extrathyroidal extension,
plump cells
Related subjects:
Medicine,
Clinical medicine,
Clinical medicine, other

© 2016 Adela Nechifor-Boilă, Ancuţa Elena Zahan, Oana Căpraru, Ramona Cătană, Andreea Fișus, Nicole Berger, published by University of Medicine, Pharmacy, Science and Technology of Targu Mures
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 License.

Volume 62 (2016): Issue 1 (March 2016)
Previous article
Next article